Anygen Co., Ltd.

A196300

KR7196300008

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
15,300 ^KRW	0.00%		-0.07%	+4.08%

Apr. 05	Anygen Co., Ltd. announced that it has received KRW 999.98709 million in funding	CI
Mar. 28	Anygen Co., Ltd. announced that it expects to receive KRW 999.98709 million in funding	CI

ANYGEN Co. Ltd. has filed an IPO.

August 12, 2015 at 12:00 am EDT

ANYGEN Co. Ltd. has filed an IPO.

Security Name: Shares
Security Type: Common Stock
PriceRange: KRW 24000 to KRW 28000

Transaction Features: Sponsor Backed Offering

Latest news about Anygen Co., Ltd.

Anygen Co., Ltd. announced that it has received KRW 999.98709 million in funding	Apr. 04	CI
Anygen Co., Ltd. announced that it expects to receive KRW 999.98709 million in funding	Mar. 27	CI
ANYGEN Co.,Ltd announced that it has received KRW 15 billion in funding from Atinum Investment Co., Ltd., Kiwoom Securities Co., Ltd., Investment Arm	18-06-07	CI
ANYGEN Co.,Ltd announced that it expects to receive KRW 15 billion in funding from Atinum Investment Co., Ltd., Kiwoom Securities Co., Ltd., Investment Arm	18-06-04	CI
An unknown buyer acquired 5.6% stake in ANYGEN Co.,Ltd from KDB Capital Corp.	17-02-07	CI
KDB Capital Corp. acquired 8.89% stake in ANYGEN Co. Ltd..	16-12-11	CI
ANYGEN Co. Ltd. has completed an IPO in the amount of KRW 12.6 billion.	16-12-06	CI
ANYGEN Co. Ltd. has filed an IPO.	15-08-12	CI

ANYGEN CO., LTD. is a Korea-based company mainly engaged in manufacture and distribution of peptides. The Company's products mainly consist of leuprorelin acetate, desmopressin acetate, and contract manufacturing organization (CMO) peptides, which are used for pharmaceuticals; custom peptides, which is used for research, and argireline, which is used for cosmetics. The Company distributes its products within domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ANYGEN CO., LTD.	+4.08%	67.8M
NOVO NORDISK A/S	+21.85%	546B
JOHNSON & JOHNSON	-4.77%	359B
MERCK & CO., INC.	+16.97%	323B
ABBVIE INC.	+5.69%	290B
ASTRAZENECA PLC	+13.68%	234B
NOVARTIS AG	+3.65%	198B
ROCHE HOLDING AG	-11.12%	194B
AMGEN INC.	+8.08%	167B
PFIZER, INC.	-3.40%	157B